Journal List > Tuberc Respir Dis > v.61(2) > 1000976

TOOLS
Lee and Lee: Respiratory Review of 2006 -Asthma-
Review
Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases 2006; 61(2): 114-120.

Published online: 31 August 2006

DOI: https://doi.org/10.4046/trd.2006.61.2.114

Respiratory Review of 2006 -Asthma-

Ka Young Lee, M.D., Yong Chul Lee, M.D., Ph.D.

Department of Internal Medicine, Airway Remodeling Laboratory, Chonbuk National University Medical School, Jeonju, South Korea.

Address for correspondence: Yong Chul Lee, M.D., Department of Internal Medicine, Chonbuk National University Medical School, San 2-20 Geumam-dong, Deokjin-gu, Jeonju, Jeonbuk 561-180, South Korea. Phone: 82-63-250-1664, Fax: Fax: 82-63-254-1609, leeyc@chonbuk.ac.kr

Copyright © 2006 The Korean Academy of Tuberculosis and Respiratory Diseases

Acknowledgement

This work was supported by grants from the National Research Laboratory Program of the Korea Science and Engineering Foundation and the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea. (A060169)

References

1. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med. 2000. 162:2341–2351.
2. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 1994. 10:471–480.
3. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 1992. 89:958–967.
4. Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med. 1995. 152:76–80.
5. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N Engl J Med. 2006. 354:697–708.
6. Ohkawara Y, Yamauchi K, Tanno Y, Tamura G, Ohtani H, Nagura H, et al. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol. 1992. 7:385–392.
7. Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W, et al. Tumor necrosis factor (TNF-α) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax. 2005. 60:1012–1018.
8. Erzurum SC. Inhibition of tumor necrosis factor α for refractory asthma. N Engl J Med. 2006. 354:754–758.
9. Choi IW, Kim YS, Kim DK, Choi JH, Seo KH, Im SY, et al. Platelet-activating factor-mediated NF-κB dependency of a late anaphylactic reaction. J Exp Med. 2003. 198:145–151.
10. Choi IW, Kim S, Kim YS, Ko HM, Im SY, Kim JH, et al. TNF-α induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phsopholipase A(2) activation. J Allergy Clin Immunol. 2005. 116:537–543.
11. Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic disease. J Allergy Clin Immunol. 2005. 116:961–968.
12. Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006. 116:146–155.
13. Hawrylowicz C, Richards D, Loke TK, Corrigan C, Lee T. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. J Allergy Clin Immunol. 2002. 109:369–370.
14. John M, Lim S, Seybold J, Jose P, Robichaud A, O'Connor B, et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med. 1998. 157:256–262.
15. Homer RJ, Elias JA. Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology. 2005. 20:28–35.
16. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeablity, and angiogenesis. Am J Pathol. 1995. 146:1029–1039.
17. Lee YC, Lee HK. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol. 2001. 107:1106.
18. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol. 2001. 107:1034–1038.
19. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001. 107:295–301.
20. Lee YC, Kwak YG, Song CH. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol. 2002. 168:3595–3600.
21. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances Th2-meidated sensitization and inflammation in the lung. Nat Med. 2004. 10:1095–1103.
22. Chetta A, Zanini A, Foresi A, D'Ippolito R, Tipa A, Castagnaro A, et al. Vascular endothelial growth factor up-regulation and bronchial wall remodeling in asthma. Clin Exp Allergy. 2005. 35:1437–1442.
23. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, et al. Interluekin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1. J Exp Med. 2001. 194:809–821.
24. Karagiannidis C, Hense G, Martin C, Epstein M, Ruckert B, Mantel PY, et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-β-mediated airway remodeling in asthma. J Allergy Clin Immunol. 2006. 117:111–118.
25. Ezeamuzie CI, Sukumaran J, Philips E. Effect of wortmannin on humna esoinophil responses in vitro and on bronchial inflammation and airwa hyperresponsiveness inGuinea pigs in vivo. Am J Respir Crit Care Med. 2001. 164:1633–1639.
26. Tigani B, Hannon JP, Mazzoni L, Fozard JR. Effects of wortmannin on airways inflammation induced by allergen in actively sensitised Brown Norway rats. Eur J Pharmacol. 2001. 433:217–223.
27. Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, Lee KS, et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest. 2003. 111:1083–1092.
28. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med. 2002. 53:409–435.
29. Lee KS, Park SJ, Hwang PH, Yi HK, Song CH, Chai OH, et al. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN. FASEB J. 2005. 19:1033–1035.
30. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996. 14:649–683.
31. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-kappa B, in asthma. Am J Respir Crit Care Med. 1998. 158:1585–1592.
32. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med. 1998. 158:1958–1962.
33. Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med. 1994. 180:711–715.
34. Kim SR, Lee KS, Park HS, Park SJ, Min KH, Jin SM, et al. Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma. Mol Pharmacol. 2005. 68:1568–1575.
35. Lee KS, Lee HK, Hayflick JS, Lee YC, Puri KD. Inhibition of phosphoinositide 3-kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J. 2006. 20:455–465.
36. van Schalkwyk E, Strydom K, Williams Z, Venter L, Leichtl S, Schmid-Wirlitsch C, et al. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions. J Allergy Clin Immunol. 2005. 116:292–298.
37. Lipworth BJ. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet. 2005. 365:167–175.
TOOLS
Similar articles